US Stock MarketDetailed Quotes
ZTS Zoetis
- 177.740
- +2.040+1.16%
Trading Nov 27 15:30 ET
80.19BMarket Cap33.41P/E (TTM)
179.270High175.120Low1.42MVolume175.725Open175.700Pre Close252.35MTurnover0.32%Turnover Ratio35.06P/E (Static)451.17MShares199.93352wk High15.32P/B80.05BFloat Cap144.11252wk Low1.67Dividend TTM450.38MShs Float242.794Historical High0.94%Div YieldTTM2.36%Amplitude25.989Historical Low178.098Avg Price1Lot Size
About Zoetis Company
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Company Profile
SymbolZTS
Company NameZoetis
Listing DateFeb 1, 2013
Issue Price26.00
Founded1952
CEOMs. Kristin C. Peck
MarketNYSE
Employees14100
Fiscal Year Ends12-31
Address10 Sylvan Way
CityParsippany
ProvinceNew Jersey
CountryUnited States of America
Zip Code07054
Phone1-973-822-7000
Websitehttp://www.zoetis.com
Company Executives
- Name
- Position
- Salary
- Kristin C. Peck
- Director and Chief Executive Officer
- 15.24M
- Roxanne Lagano
- Chief Human Resources Officer, Executive Vice President, Global Operations and Interim General Counsel and Corporate Secretary
- --
- Wetteny Joseph
- Executive Vice President, Principal Accounting Officer and Chief Financial Officer
- 4.25M
- Keith Sarbaugh
- Executive Vice President and Chief Digital Officer and Chief Technology Officer
- --
- Jamie Brannan
- Executive Vice President and Chief Commercial Officer
- --
- Jeannette Ferran Astorga
- Executive Vice President, Corporate Affairs, Communications and Chief Sustainability Officer
- --
- Nick Ashton
- Executive Vice President and President, Global Manufacturing and Supply
- --
- Rimma Driscoll
- Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
- --
- Dr. Robert J. Polzer, PhD
- Executive Vice President and President, Research and Development
- 2.44M
- Michael B. McCallister
- Non-Executive Chairman of the Board
- 490.00K
- Jared Shriver
- President, U.S. Operations
- --
- Gavin D.K. Hattersley
- Director
- --
- Vanessa Broadhurst
- Independent Director
- 341.00K
- Dr. Willie M. Reed
- Independent Director
- 370.00K
- Gregory Norden
- Independent Director
- 365.00K
- Frank A. D'Amelio
- Independent Director
- 340.50K
- Sanjay Khosla
- Independent Director
- 340.00K
- Antoinette R. Leatherberry
- Independent Director
- 340.00K
- Robert W. Scully
- Independent Director
- 365.00K
- Paul M. Bisaro
- Independent Director
- 340.00K
- Louise M. Parent
- Independent Director
- 370.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data